Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
COVID-19-gerelateerde ARDS-subgroepen, verschillende respons op corticosteroïden
dec 2021 | Pneumonie, Virale infecties